3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Interventions
Androgen Antagonists
9
darolutamide
6
Magnetic Resonance Spectroscopy
6
enzalutamide
5
apalutamide
5
Docetaxel
5
Specimen Handling
4
Radiotherapy
4
Abiraterone Acetate
4
Prednisone
3
Electroacupuncture
3
Brachytherapy
3
pembrolizumab
2
Standard of Care
2
Resistance Training
2
Radiosurgery
2
Radiation
2
Pluvicto
2
Interviews as Topic
2
Gonadotropin-Releasing Hormone
2
Glutamate Carboxypeptidase II
2
Bone Density
2
Absorptiometry, Photon
2
testosterone 17 beta-cypionate
1
relugolix
1
perflutren
1
olaparib
1
luprolide acetate gel depot
1
fluciclovine F-18
1
fezolinetant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Prostatic Neoplasms
×
Self-Management
×
Clear all
NCT07264088
2026-04-16
FOLLOW-UP
Imperial College London
Not yet recruiting
100,000 enrolled